Vivanza Biosciences Ltd. (VIVANZA) Share Price Surges 8.84% Today

Vivanza Biosciences Ltd. Share Price surged 8.84% to Rs 1.97, marking a significant rise in the micro-cap category.

Vivanza Biosciences Ltd. Share Price experienced a notable surge today, rising by 8.84% to reach Rs 1.97. This increase is significant, especially for a micro-cap company with a market capitalisation of Rs 7.52 crore. The stock's performance today highlights its position as a top gainer in its category, surpassing the qualifying threshold of 8.1% set for micro-cap stocks. This price rise has drawn attention from investors and analysts alike, as it reflects a strong market interest in Vivanza Biosciences Ltd.

The company's share price opened and reached its high and low at Rs 1.97, indicating a consistent trading pattern throughout the day. With a total volume of 500 shares traded on the BSE, the turnover remained at Rs 0 crore, suggesting limited trading activity despite the price increase. This movement in share price underscores the potential volatility and interest in micro-cap stocks like Vivanza Biosciences Ltd.

Vivanza Biosciences Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1.97
Previous Close	Rs 1.81
Today's Change	+Rs 0.16 (+8.84%)
Day Open	Rs 1.97
Day High	Rs 1.97
Day Low	Rs 1.97
Current Volume (BSE)	500
BSE Traded Volume	500
Combined NSE + BSE Volume	500
Turnover	Rs 0 crore
Market Capitalisation	Rs 7.52 crore
Market Cap Category	Micro Cap
Qualifying Threshold Cleared	8.1%

Today's price action for Vivanza Biosciences Ltd. saw the share price rise from a previous close of Rs 1.81 to a current price of Rs 1.97, marking a day change of Rs 0.16 or 8.84%. The stock opened, peaked, and bottomed out at Rs 1.97, indicating a stable trading session. Despite the significant price rise, the total turnover was Rs 0 crore, reflecting limited trading volume of 500 shares on the BSE.

Vivanza Biosciences Ltd. is classified as a micro-cap stock, with a market capitalisation of Rs 7.52 crore. The stock's 8.84% rise today exceeded the qualifying threshold of 8.1% for its market-cap category, highlighting its status as a top gainer. This movement has captured the attention of market participants, as micro-cap stocks often exhibit higher volatility and potential for rapid price changes.

Vivanza Biosciences Ltd. Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 7.52 crore
P/E Ratio	18.38x
P/B Ratio	1.66x
ROE	2.41%
ROCE	17.11%
EPS	Rs 0.1
Book Value Per Share	Rs 1.09
Dividend Yield	0%

Vivanza Biosciences Ltd. was valued at a P/E ratio of 18.38x, a P/B ratio of 1.66x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 2.41% and ROCE of 17.11%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 0.1, book value per share of Rs 1.09, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Vivanza Biosciences Ltd. operates within the trading sector, with a market capitalisation of Rs 7.52 crore. The company's valuation metrics include a P/E ratio of 18.38 and a P/B ratio of 1.66, indicating a moderate valuation compared to its peers. The Return on Equity (ROE) is 2.41%, while the Return on Capital Employed (ROCE) stands at 17.11%, reflecting the company's efficiency in generating returns on shareholder equity and capital employed.

The company's Earnings Per Share (EPS) is Rs 0.1, and the book value per share is Rs 1.09, providing insights into the company's profitability and net worth per share. The absence of a dividend yield suggests that the company may be reinvesting its profits for growth rather than distributing them to shareholders.

Vivanza Biosciences Ltd.'s valuation metrics, such as the P/E and P/B ratios, are in line with industry benchmarks, with the company's P/E ratio slightly above the industry median of 14.63. The ROE and ROCE figures indicate a relatively strong performance compared to industry averages, highlighting the company's ability to generate returns efficiently.

Sector and Industry Context

Metric	Value
Sector	Trading
Industry	Trading
Benchmark Scope	same industry
Companies in Benchmark	435
Company P/E Ratio	18.38x
Benchmark Median P/E	14.63x
Benchmark Average P/E	71.58x
Benchmark P/E Range	0x to 2,181.81x
Companies with P/E Data	435
Company P/B Ratio	1.66x
Benchmark Median P/B	1.31x
Company ROE	2.41%
Benchmark Median ROE	1.97%
Company ROCE	17.11%
Benchmark Median ROCE	3.89%
Company Market Capitalisation	Rs 7.52 crore
Benchmark Median Market Cap	Rs 47.16 crore

Vivanza Biosciences Ltd. (VIVANZA) is classified under sector: Trading and industry: Trading. The numerical benchmark uses 435 same industry companies from the supplied master-data set.

Vivanza Biosciences Ltd. (VIVANZA) has a P/E ratio of 18.38x, which is above the benchmark median of 14.63x, a difference of +25.63%. The benchmark contains 435 companies with P/E data, ranging from 0x to 2,181.81x. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Vivanza Biosciences Ltd. (VIVANZA) has a ROE of 2.41%, which is above the benchmark median of 1.97%, a difference of +22.34%. Vivanza Biosciences Ltd. (VIVANZA) has a ROCE of 17.11%, which is above the benchmark median of 3.89%, a difference of +339.85%.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

Vivanza Biosciences Ltd. operates within the trading sector, which comprises 435 companies. The company's P/E ratio of 18.38 is above the industry median of 14.63, indicating a relatively higher valuation compared to its peers. The P/B ratio of 1.66 also surpasses the industry median of 1.31, suggesting a premium valuation in terms of book value.

The company's ROE of 2.41% is above the industry median of 1.97%, while its ROCE of 17.11% significantly exceeds the industry median of 3.89%. These figures highlight Vivanza Biosciences Ltd.'s strong performance in generating returns compared to its industry counterparts.

The trading sector's market capitalisation ranges from Rs 1.07 crore to Rs 2,596.46 crore, with Vivanza Biosciences Ltd.'s market cap of Rs 7.52 crore placing it on the lower end of the spectrum. Despite its smaller size, the company's financial metrics indicate a competitive position within the industry.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Reetech International Cargo and Courier Ltd.	REETECH	7.59	18.52	0.65	8.72	10.44
Priya Ltd.	PRIYALT	7.33	1.69	-0.16	0	0
Parker Agrochem Exports Ltd.	PARKERAC	7.29	8.47	1.54	-50.16	-27.99
Sirohia & Sons Ltd.	SIROHIA	7.81	252.08	0.28	-0.06	0.34
Scan Projects Ltd.	SCANPRO	7.87	11.01	1.93	2.22	3.56

Vivanza Biosciences Ltd. (VIVANZA) has a P/E ratio of 18.38x compared with the displayed peer median of 11.01x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 2.41% compares with a peer median of 0% across the companies shown in the table. ROCE stood at 17.11% versus the displayed peer median of 0.34%, providing a capital-efficiency comparison. Vivanza Biosciences Ltd. (VIVANZA) has a market capitalisation of Rs 7.52 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Vivanza Biosciences Ltd. faces competition from several peers within the trading industry. Reetech International Cargo and Courier Ltd. has a market cap of Rs 7.59 crore, with a P/E ratio of 18.52 and a ROE of 8.72%. Priya Ltd. has a lower P/E ratio of 1.69 but a negative P/B ratio of -0.16, indicating potential financial challenges.

Parker Agrochem Exports Ltd. has a P/E ratio of 8.47 and a P/B ratio of 1.54, with negative ROE and ROCE figures, suggesting inefficiencies in generating returns. Sirohia & Sons Ltd. has a high P/E ratio of 252.08, reflecting a premium valuation despite a negative ROE. Scan Projects Ltd. offers a balanced profile with a P/E ratio of 11.01 and a ROE of 2.22%.

Vivanza Biosciences Ltd.'s financial metrics, such as its P/E and ROE, position it competitively among its peers, with a moderate valuation and efficient return generation.

Why Investors Are Watching Vivanza Biosciences Ltd.

Investors are closely monitoring Vivanza Biosciences Ltd. due to its recent price surge and competitive financial metrics.

• Price Action: 8.84% rise to Rs 1.97, exceeding the micro-cap threshold.
• Technical Position: Neutral RSI at 51.73, indicating balanced sentiment.
• Fundamental Context: Moderate P/E and P/B ratios, strong ROCE.
• Sector Positioning: Competitive metrics within the trading sector.

Investors should continue to observe Vivanza Biosciences Ltd.'s market performance, technical indicators, and sector dynamics to make informed decisions.

About Vivanza Biosciences Ltd.

Vivanza Biosciences Ltd. operates in the trading industry, focusing on the distribution and sale of various products. The company leverages its market position to engage in trading activities, contributing to its revenue streams. As a micro-cap entity, Vivanza Biosciences Ltd. navigates the competitive landscape of the trading sector, aiming to capitalize on market opportunities and enhance its financial performance.

The company's business model revolves around efficient trading operations, with an emphasis on maximizing returns on capital employed. Vivanza Biosciences Ltd. continues to explore growth avenues within the trading industry, seeking to strengthen its market presence and deliver value to its stakeholders.

Track Vivanza Biosciences Ltd. Share Price on Univest

Use Vivanza Biosciences Ltd. (VIVANZA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors can track Vivanza Biosciences Ltd. Share Price on Univest to stay updated on live price movements, technical indicators, and fundamental ratios. Univest provides comprehensive insights into the company's shareholding pattern, 52-week levels, and market trends, enabling investors to make informed decisions based on real-time data and analysis.

Frequently Asked Questions

What is the current share price of Vivanza Biosciences Ltd.?

Ans. The current share price of Vivanza Biosciences Ltd. is Rs 1.97, reflecting an 8.84% increase from the previous close of Rs 1.81. The stock moved 8.84% during the session. The intraday range extended from Rs 1.97 to Rs 1.97.

How much did Vivanza Biosciences Ltd. share price rise today?

Ans. Vivanza Biosciences Ltd. share price rose by 8.84% today, marking a significant increase in the micro-cap category. The stock moved 8.84% during the session. The intraday range extended from Rs 1.97 to Rs 1.97.

What is the market capitalisation of Vivanza Biosciences Ltd.?

Ans. The market capitalisation of Vivanza Biosciences Ltd. is Rs 7.52 crore, classifying it as a micro-cap stock. The company operates in the Trading sector. Its P/E ratio is 18.38x. ROE is 2.41% and ROCE is 17.11%.

What is the P/E ratio of Vivanza Biosciences Ltd.?

Ans. Vivanza Biosciences Ltd. has a P/E ratio of 18.38, indicating a moderate valuation compared to industry peers. The company trades at a P/E ratio of 18.38x. Its P/B ratio is 1.66x.

What is the ROE of Vivanza Biosciences Ltd.?

Ans. The Return on Equity (ROE) for Vivanza Biosciences Ltd. is 2.41%, reflecting its efficiency in generating shareholder returns. ROE stands at 2.41%. ROCE stands at 17.11%. The relevant peer median ROE is 1.97%.

How does Vivanza Biosciences Ltd. compare to its peers?

Ans. Vivanza Biosciences Ltd. has competitive financial metrics, with a moderate P/E ratio and efficient ROE compared to its peers in the trading sector. Comparable listed companies include Reetech International Cargo and Courier Ltd., Priya Ltd., Parker Agrochem Exports Ltd.

What sector does Vivanza Biosciences Ltd. operate in?

Ans. Vivanza Biosciences Ltd. operates in the trading sector, engaging in the distribution and sale of various products. The stock belongs to the Trading sector. Its industry classification is Trading. 435 comparable companies were included in the benchmark.

What is the ROCE of Vivanza Biosciences Ltd.?

Ans. The Return on Capital Employed (ROCE) for Vivanza Biosciences Ltd. is 17.11%, highlighting its efficiency in using capital to generate returns. ROE stands at 2.41%. ROCE stands at 17.11%. The relevant peer median ROE is 1.97%.